Official recall notice

FDA DrugClass IINotable

FDA Recall: Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwe

Recall date
2026-04-22
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Lack of Assurance of Sterility

Recommended action

What to do

91 vials

Product description

Lack of Assurance of Sterility

Verify with the official notice →
Share:

Related Recalls

2026-09-21 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL)
Par Pharmaceutical
2026-09-21 · FDA_DRUG
FDA Recall: ICU Medical LLC: 0.9% Sodium Chloride Injection, USP, 100 mL
ICU Medical LLC
2026-09-16 · FDA_DRUG
FDA Recall: Povidone Iodine 1.25% / Proparacaine HCl 0.5% Ophthalmic Solution, 10 mL per dropper bottle, For Off
ImprimisRx NJ LLC
2026-09-16 · FDA_DRUG
FDA Recall: Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharm
Ajanta Pharma USA Inc